Retinal Implant Market Size, Emerging Trends and Outlook to 2022: Hexa Reports

Hexa Reports
Market Research Reports and Insightful Company Profiles

Retinal Implant Market Analysis, Share and Size, Emerging
Trends, Overview and Outlook, Growth And Segment
Forecasts To 2022

The global retinal implant market for is expected to reach over USD 1,117 million by 2022, according to a
new report by Grand View Research, Inc. Some key drivers of the bionic eye market include rising
burden of blindness with increasing aging population and successful completion of clinical trials resulting
in entry of breakthrough technologies in the market.
Growing age is one of the prime factors resulting in expansion of visually impaired patients in the world.
According to the World Health Organization (WHO), around 65% of the total visually impaired
population globally (i.e., approximately 285 million) is aged 50 or more.
Browse Detail Report With TOC @ http://hexareports.com/report/retinal-implant-market/details
Additionally, the visually impaired population aged above 50 years accounts for 20% of the global
population. Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP) are the most
common causes of blindness. According to the WHO, AMD is the third leading cause of visual
impairment with a prevalence rate of 8.7%. Considering growth of target population, demand for retinal
prosthetics is anticipated to rise swiftly during the forecast period.
Moreover, alternative therapies such as anti-angiogenic drugs, laser therapy, Photodynamic Laser
Therapy (PTD), and vitamins fail to completely cure AMD and RP. These treatments delay the vision loss
with slowing progression of the disease. However, devices such as Argus II and miniature telescope are

Hexa Reports
Market Research Reports and Insightful Company Profiles
capable of restoring the vision in blind patients. As a result, adoption of retinal implants is escalating
with rising awareness about the availability of the product in the market.
On the other hand, high cost of commercially available...